Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vita Life Sciences Limited ( (AU:VLS) ) has provided an update.
Vita Life Sciences Limited has announced an update regarding its ongoing on-market buy-back program. As of October 17, 2025, the company has repurchased a total of 287,413 ordinary fully paid shares, including 23,000 shares bought back on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of vitamins, supplements, and other health-related products. The company is known for its commitment to enhancing health and well-being through scientifically-backed products.
Average Trading Volume: 10,304
Technical Sentiment Signal: Buy
Current Market Cap: A$131.9M
For a thorough assessment of VLS stock, go to TipRanks’ Stock Analysis page.